Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures

Blood

Volumn 99, Issue 9, 2002, Pages 3302-3309

  Sun, Qi ^a   Burton, Robert L ^a   Lucas, Kenneth G ^a,b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CONCANAMYCIN A; CYTOKINE; EGTAZIC ACID; FAS LIGAND; GAMMA INTERFERON; GRANULYSIN; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; EXOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 0036566547     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.9.3302     Document Type: Article

References (48)

1. Accessing complexity: The dynamics of virus-specific T cell responses
2. + T cell effector mechanisms in resistance to infection
3. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches
4. Immune response to viruses
5. The Epstein-Barr virus and the immune system
6. Cytomegalovirus
7. Principles for adoptive T cell therapy of human viral diseases
8. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
9. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoprofiferation
10. Human cytomegalovirus-specific cytotoxic T lymphocytes: Requirements for in vitro generation and specificity
11. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
12. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
13. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65
14. Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells
15. B-lymphoblastoid cell lines as efficient antigen-presenting cells to elicit CD8+ T cell responses to a cytomegalovirus antigen
16. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL
17. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones
18. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation
19. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction
20. T-cell repertoire diversity and clonal expansions in normal and clinical samples
21. Functional diversity of helper T lymphocytes
22. Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells
23. Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells
24. Cutting edge: OFF cycling of TNF production by antigen-specific CD8(+) T cells is antigen independent
25. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
26. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lyric pathways in cell-mediated cytotoxicity
27. The regulation of CD95 ligand expression and function in CTL
28. Ca2+ signaling modulates cytolytic T lymphocyte effector functions
29. Antigen receptor-regulated exocytosis in cytotoxic T lymphocytes
30. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins
31. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood
32. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes
33. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells
34. Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide
35. Human CD4+ T Lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
36. A phase I-II trial to examine the toxicity of CMV and EBV specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34 selected/T cell depleted stem cell transplants
37. Single cell analysis of cytokine gene coexpression during CD4+ T-cell phenotype development
38. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity
39. Single-cell analysis by RT-PCR reveals differential expression of multiple type 1 and 2 cytokine genes among cells within polarized CD4+ T cell populations
40. Clinical implications of dysregulated cytokine production
41. TNF-related apoptosisinducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
42. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells
43. Granulysin: A novel antimicrobial
44. CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis
45. T-cell release of granulysin contributes to host defense in leprosy
46. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity
47. Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells
48. A distinct pathway of cell-mediated apoptosis initiated by granulysin